VIVID: high-dose vitamin D3 did not reduce COVID-19 severity in a randomized trial
Louis reports the Harvard-led VIVID trial: 1,747 COVID patients and 277 contacts randomized to vitamin D3 or placebo for four weeks showed no difference in healthcare use, death or symptoms, though a signal for less long COVID emerged.